The Safety and Serious Adverse Events of Approved ALK Inhibitors in Malignancies: A Meta-Analysis

Cancer Management and Research - New Zealand
doi 10.2147/cmar.s190098
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy